Atrial Fibrillation (AFib) clinical trials in Ohio
31 active Atrial Fibrillation (AFib) trials with a site in Ohio. Describe your situation to see which ones look like a fit.
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
- Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
- Medtronic Terminate AF Study
- Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study
- Sleep Apnea Triggers of Atrial Fibrillation: N-of-1 Randomized Control Trial (SPARTA):
- The Fourth Left Atrial Appendage Occlusion Study
- A Study of Assessment on Safety and Effectiveness of BWI Pulsed Field Ablation With OMNYPULSE Catheter for the Treatment of Paroxysmal Atrial Fibrillation (PAF)
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
- A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- Low Voltage-Directed Catheter Ablation for Atrial Fibrillation
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- The CONFORM Pivotal Trial
- Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
- Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable
- The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Direct Comparison of Cardiac CT With TEE to Evaluate Watchman FLX LAA Occluder Device Characteristics
- Intracardiac Echocardiography Guided Watchman Device Implant
- Surveillance Trial of the Apple Watch in Reliable Burden Assessment in Unseen Recurrence of Surgically Treated AF
- PULSED AF Post-Approval Study
- Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
- Tracking Results of Ablations to Combat AF Registry Generation 2
- Development of CIRC Technologies
- Biospecimen Repository for Cardiac Arrhythmias at the Cleveland Clinic
- Metabolic Surgery for Atrial Fibrillation Elimination
- Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation
- Developing MRI Technologies for Atrial Fibrillation
- A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF
- A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.